These suggest that hydrocephalus might have also affected basal ganglia activity by reducing the action of dopamine on the direct pathway earlier than the indirect pathway since d and i-MSNs express principally DR1 and DR2 respectively. The gene discussed is DR1; the disease is Hydrocephalus.